Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -10,947 | -8,064 |
| Depreciation Amortization | 447 | 303 |
| Accounts receivable | N/A | -3,000 |
| Accounts payable and accrued liabilities | 1,924 | 1,662 |
| Other Working Capital | 2,828 | -514 |
| Other Operating Activity | -2,512 | 683 |
| Operating Cash Flow | $-8,260 | $-8,930 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -944 | -944 |
| Investing Cash Flow | $-944 | $-944 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 2,781 | N/A |
| Debt Issued | 1,254 | 1,254 |
| Financing Cash Flow | $4,035 | $1,254 |
| Beginning Cash Position | 16,536 | 16,536 |
| End Cash Position | 11,367 | 7,916 |
| Net Cash Flow | $-5,169 | $-8,620 |
| Free Cash Flow | ||
| Operating Cash Flow | -8,260 | -8,930 |
| Capital Expenditure | -944 | -944 |
| Free Cash Flow | -9,204 | -9,874 |